CRI Earnings

CRI reported its earnings on 2026-02-27, showcasing a revenue of against an estimate of 866.75M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 1.7 by 0%. The stock experienced a -20.25% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CRI's earnings announcement on 2026-02-27, the stock price moved by -20.25% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CRI's stock price tends to shift by an average of 8.4% in the 10 days leading up to earnings and 0.74% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CRI's annual revenue to reach 641.55M, while the EPS is projected at 0.24. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CRI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CRI's stock price typically moves by 8.4% in the 10 days before its earnings and 0.74% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.24 and revenue of 641.55M.

The earnings call presents a mixed picture: strong growth in emerging brands and e-commerce, but challenges with tariffs and wholesale pricing. Despite optimistic guidance and strategic initiatives like cost reduction and marketing investments, the lack of clarity on tariff impacts and weak wholesale performance weigh on sentiment. The Q&A reveals cautious optimism but also uncertainty, particularly regarding tariffs. Given the market cap of $2.26 billion, the stock is likely to remain stable, with minor fluctuations, resulting in a neutral prediction (-2% to 2%).